Henrik Vestergaard

19.5k total citations · 3 hit papers
157 papers, 6.5k citations indexed

About

Henrik Vestergaard is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Henrik Vestergaard has authored 157 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 41 papers in Physiology and 39 papers in Surgery. Recurrent topics in Henrik Vestergaard's work include Metabolism, Diabetes, and Cancer (46 papers), Diet and metabolism studies (24 papers) and Pancreatic function and diabetes (22 papers). Henrik Vestergaard is often cited by papers focused on Metabolism, Diabetes, and Cancer (46 papers), Diet and metabolism studies (24 papers) and Pancreatic function and diabetes (22 papers). Henrik Vestergaard collaborates with scholars based in Denmark, United States and Germany. Henrik Vestergaard's co-authors include Oluf Pedersen, Camilla Noelle Rathcke, Torben Hansen, Thomas Almdal, Jan Skov Jensen, Henrik Scharling, Christian Bjørbæk, Peter Laurberg, Tue H. Hansen and Klaus M. Pedersen and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Henrik Vestergaard

151 papers receiving 6.3k citations

Hit Papers

The Independent Effect of Type 2 Diabetes Mellitus on Isc... 2004 2026 2011 2018 2004 2018 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death
    2004 511 citations Thomas Almdal, Henrik Vestergaard et al. profile →
  2. Aberrant intestinal microbiota in individuals with prediabetes
    2018 339 citations Kristine H. Allin, Martin Iain Bahl et al. profile →
  3. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum
    2018 330 citations Mie Crusell, Tue H. Hansen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Vestergaard Denmark 43 3.3k 1.6k 1.5k 1.3k 602 157 6.5k
Cheng Hu China 42 2.5k 0.7× 1.4k 0.9× 1.2k 0.8× 1.1k 0.9× 1.2k 2.0× 274 6.2k
Edgard Delvin Canada 50 1.4k 0.4× 1.1k 0.7× 939 0.6× 1.2k 1.0× 911 1.5× 157 6.4k
Gail W. Sullivan United States 33 1.4k 0.4× 1.6k 1.0× 1.2k 0.8× 729 0.6× 1.1k 1.9× 54 6.3k
George Dimitriadis Greece 40 1.4k 0.4× 2.1k 1.3× 1.3k 0.9× 1.1k 0.9× 810 1.3× 185 5.6k
Pierre Gourdy France 45 1.9k 0.6× 1.9k 1.2× 1.2k 0.8× 986 0.8× 1.2k 2.0× 190 8.1k
Niels P. Riksen Netherlands 50 2.4k 0.7× 688 0.4× 684 0.5× 1.1k 0.9× 1.1k 1.9× 205 9.5k
Pravin C. Singhal United States 45 2.2k 0.7× 587 0.4× 812 0.5× 1.1k 0.8× 664 1.1× 301 7.4k
Chikako Ito Japan 27 1.3k 0.4× 1.7k 1.0× 875 0.6× 837 0.7× 746 1.2× 70 4.9k
Mark O. Goodarzi United States 47 1.8k 0.5× 1.7k 1.0× 819 0.5× 1.0k 0.8× 928 1.5× 168 7.7k
S. Raptis Greece 45 1.3k 0.4× 2.3k 1.5× 1.1k 0.7× 1.9k 1.5× 1.3k 2.2× 231 6.9k

Countries citing papers authored by Henrik Vestergaard

Since Specialization
Citations

This map shows the geographic impact of Henrik Vestergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Vestergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Vestergaard more than expected).

Fields of papers citing papers by Henrik Vestergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Vestergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Vestergaard. The network helps show where Henrik Vestergaard may publish in the future.

Co-authorship network of co-authors of Henrik Vestergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Vestergaard. A scholar is included among the top collaborators of Henrik Vestergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Vestergaard. Henrik Vestergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wretlind, Asger, Viktor Rotbain Curovic, Tommi Suvitaival, et al.. (2023). Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes. Diabetes. 72(10). 1493–1501. 13 indexed citations
2.
Aasbrenn, Martin, Mathilde Svendstrup, Theresia M. Schnurr, et al.. (2021). Genetic markers of abdominal obesity and weight loss after gastric bypass surgery. PLoS ONE. 16(5). e0252525–e0252525. 7 indexed citations
3.
Almdal, Thomas, Peter Vestergaard, Louise Lundby‐Christensen, et al.. (2021). Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial. Osteoporosis International. 32(9). 1837–1848. 10 indexed citations
4.
Hansen, Katrine Bagge, Mathilde Svendstrup, Asger Lund, et al.. (2021). Once‐weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real‐world data from a diabetes out‐patient clinic. Diabetic Medicine. 38(10). e14655–e14655. 19 indexed citations
5.
Larsen, Emil List, Louise Lundby‐Christensen, Trine Welløv Boesgaard, et al.. (2021). Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial. Free Radical Biology and Medicine. 178. 18–25. 1 indexed citations
6.
Almdal, Thomas, Peter Vestergaard, Louise Lundby‐Christensen, et al.. (2020). Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus. Calcified Tissue International. 107(2). 160–169. 10 indexed citations
7.
Rasmussen, Malene Bøgehus, Mana M. Mehrjouy, Lusine Nazaryan‐Petersen, et al.. (2019). Haploinsufficiency of ARHGAP42 is associated with hypertension. European Journal of Human Genetics. 27(8). 1296–1303. 12 indexed citations
8.
Suvitaival, Tommi, Ashfaq Ali, Peter Spégel, et al.. (2018). Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial. Diabetic Medicine. 35(7). 944–953. 25 indexed citations
9.
Hansen, Tue H., Niklas Rye Jørgensen, Arieh S. Cohen, et al.. (2018). Bone turnover, calcium homeostasis, and vitamin D status in Danish vegans. European Journal of Clinical Nutrition. 72(7). 1046–1054. 46 indexed citations
10.
Almdal, Thomas, Peter Vestergaard, Louise Lundby‐Christensen, et al.. (2018). The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial. Osteoporosis International. 29(11). 2517–2526. 25 indexed citations
11.
Engelbrechtsen, Line, Yuvaraj Mahendran, Mie Crusell, et al.. (2018). Birth weight variants are associated with variable fetal intrauterine growth from 20 weeks of gestation. Scientific Reports. 8(1). 8376–8376. 6 indexed citations
12.
Lind, Mads Vendelbo, Lotte Lauritzen, Henrik Vestergaard, et al.. (2018). One-carbon metabolism markers are associated with cardiometabolic risk factors. Nutrition Metabolism and Cardiovascular Diseases. 28(4). 402–410. 26 indexed citations
13.
Svendstrup, Mathilde, Kristine H. Allin, Thorkild I. A. Sørensen, et al.. (2017). Genetic risk scores for body fat distribution attenuate weight loss in women during dietary intervention. International Journal of Obesity. 42(3). 370–375. 14 indexed citations
14.
Lind, Mads Vendelbo, Lotte Lauritzen, Oluf Pedersen, et al.. (2017). Higher intake of fish and fat is associated with lower plasma s -adenosylhomocysteine: a cross-sectional study. Nutrition Research. 46. 78–87. 4 indexed citations
15.
Roager, Henrik M., Lea Benedicte Skov Hansen, Martin Iain Bahl, et al.. (2016). Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nature Microbiology. 1(9). 16093–16093. 301 indexed citations
16.
Kelstrup, Louise, Thomas F. Dejgaard, Tine D. Clausen, et al.. (2016). Levels of the inflammation marker YKL-40 in young adults exposed to intrauterine hyperglycemia. Diabetes Research and Clinical Practice. 114. 50–54.
17.
18.
Lauenborg, Jeannet, Torben Hansen, Henrik Vestergaard, et al.. (2004). Increasing Incidence of Diabetes After Gestational Diabetes. Obstetrical & Gynecological Survey. 59(10). 696–697. 3 indexed citations
19.
Vestergaard, Henrik, Christian Bjørbæk, Torben Hansen, et al.. (1995). Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.. Journal of Clinical Investigation. 96(6). 2639–2645. 73 indexed citations
20.
Vestergaard, Henrik, Sten Lund, Fin Stolze Larsen, Ole J. Bjerrum, & Oluf Pedersen. (1993). Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.. Journal of Clinical Investigation. 91(6). 2342–2350. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng Hu Breakdown of academic impact, for papers by Edgard Delvin Breakdown of academic impact, for papers by Gail W. Sullivan Breakdown of academic impact, for papers by George Dimitriadis Breakdown of academic impact, for papers by Pierre Gourdy Breakdown of academic impact, for papers by Niels P. Riksen Breakdown of academic impact, for papers by Pravin C. Singhal Breakdown of academic impact, for papers by Chikako Ito Breakdown of academic impact, for papers by Mark O. Goodarzi Breakdown of academic impact, for papers by S. Raptis
Rankless by CCL
2026